CYTIVA

Company Snapshot

Founded: 1968
Entity Type: Private
Region: U.S.
Headquarter: Massachusetts, U.S.
Key Geographics: North America, Asia-Pacific, Latin America, Europe, Middle East and Africa
Corporate Address: 100 Results Way Marlborough Massachusetts 01752 U.S. Tel. www.cytivalifesciences.com

Company Overview

Previously, GE Healthcare Life Sciences Cytiva was a worldwide leader in the life sciences with a focus on developing and expediting therapies. The company has around 16,000 employees working in 40 countries. Cytiva is a reliable partner for a variety of large and small companies. By enhancing research and manufacturing processes with speed, efficiency, and capacity, Cytiva makes it possible to create, produce, and distribute revolutionary medications to patients. Well-known brands, including ÄKTA, Amersham, Biacore, FlexFactory, HyClone, MabSelect, Sefia, Whatman, Xcellerex, and Xuri, are among the many products in Cytiva’s broad range. The portfolio includes a wide range of tools, consumables, digital and enterprise solutions, and services for process development, research, and entire production workflows that can be scaled to meet the demands of the client. In 2020, Danaher Corp. acquired Cytiva, but it has been operating under the brand name Cytiva.

CYTIVA In Reports

Cell and Gene Therapy Tools and Reagents: Global Markets

BCC Research detailed report on Cell and Gene Therapy Tools and Reagents Market covered are North America, Europe, Asia-Pacific and the Rest of the World (RoW). For market estimates, data has been provided for 2024 as...

Bioprocess Filtration: Global Markets

Our detailed report on the Bioprocess Filtration Markets report, presenting revenue estimates (in USD Millions) for the base year 2024 and market forecasts for the 2025 to 2030 period.

Cell Therapy Processing: Global Markets and Technologies

BCC Research detailed report on cell therapy processing market includes global revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030.

Company's Business Segments

  • Products : Aseptic filling, Bioprocess filtration, Cell culture and fermentation processes, Cell therapy solutions, Chromatography products, Fluid management, Lab filtration, Lipid nanoparticle instruments and reagents, Medical products, Diagnostics, Oligonucleotide synthesis, Protein analysis equipment and supplies
  • Services : LifeCycle support solutions, Regulatory support, Change Control Notifications, Scientific support, Certificate search, Handbooks, Instructions for use, Safety data sheets/SDS, Tools and calculators, Training

Applications/End User Industries

  • Biopharmaceuticals
  • Research Institutes
  • Clinical Labs
  • Cell and Gene Therapy
  • Vaccine Development
AI Sentiment